CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 21  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0678
LYS 10.0311
GLU 20.0258
LEU 30.0167
ARG 40.0144
CYS 50.0254
GLN 60.0253
CYS 70.0284
ILE 80.0089
LYS 90.0093
THR 100.0038
TYR 110.0082
SER 120.0037
LYS 130.0080
PRO 140.0146
PHE 150.0142
HIS 160.0096
PRO 170.0035
LYS 180.0094
PHE 190.0161
ILE 200.0056
LYS 210.0172
GLU 220.0128
LEU 230.0098
ARG 240.0139
VAL 250.0067
ILE 260.0096
GLU 270.0445
SER 280.0474
GLY 290.0482
PRO 300.0676
HIS 310.0241
CYS 320.0216
ALA 330.0576
ASN 340.0492
THR 350.0314
GLU 360.0153
ILE 370.0087
ILE 380.0131
VAL 390.0068
LYS 400.0047
LEU 410.0138
SER 420.0317
ASP 430.0399
GLY 440.0192
ARG 450.0262
GLU 460.0167
LEU 470.0132
CYS 480.0070
LEU 490.0066
ASP 500.0101
PRO 510.0095
LYS 520.0269
GLU 530.0185
ASN 540.0217
TRP 550.0144
VAL 560.0090
GLN 570.0111
ARG 580.0064
VAL 590.0051
VAL 600.0031
GLU 610.0026
LYS 620.0019
PHE 630.0012
LEU 640.0070
LYS 650.0114
ARG 660.0091
ALA 670.0184
GLU 680.0466
ASN 690.0678

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.